Company:  SYNEOS HEALTH, INC. (SYNH)
Form Type:  8-K
Filing Date:  12/7/2017 
CIK:  0001610950 
Address:  3201 BEECHLEAF COURT
SUITE 600
 
City, State, Zip:  RALEIGH, North Carolina 27604 
Telephone:  919-876-9300 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$49.10  
Change: 
0.20 (0.41%)  
Trade Time: 
Sep 21  
Market Cap: 
$5.05B
Trade SYNH now with 

© 2018  
Description of Business
Overview We are a leading global biopharmaceutical services organization providing product development and commercial solutions through our clinical end-to-end contract research organization ("CRO") and contract commercial organization ("CCO"). We offer both standalone and integrated biopharmaceutical solutions ranging from Early Phase (Phase I) clinical trials to the full commercialization of biopharmaceutical products. Our ability to achieve end-to-end solutions is based on our biopharmaceutical acceleration model ("BAM") where we synchronize our clinical and commercial capabilities - sharing knowledge, data, and insights. Our customers include large and small to mid-sized companies in the biopharmaceutical, biotechnology, and medical device industries. Our revenue is derived through a broad suite of services designed to enhance our customers' ability to successfully develop, launch, and market products.
Register and access this filing in:     
  FORM 8-K
    SECTION 5 CORPORATE GOVERNANCE
      Item 5.02. Departure of Directors or Certain Officers; ...
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 Financial Statements and Exhibits.
    SIGNATURE
  EXHIBIT 10.1